98264926 - RENEO PHARMACEUTICALS

Information

  • Trademark
  • 98264926
  • Serial Number
    98264926
  • Filing Date
    November 10, 2023
    a year ago
  • Transaction Date
    October 16, 2024
    a month ago
  • Status Date
    October 16, 2024
    a month ago
  • Location Date
    October 16, 2024
    a month ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 116
    Employee Name
    LE, KHANH
  • Attorney Docket Number
    48135-TM1004
    Attorney Name
    Brandon P. Leahy
    Law Office Assigned Location Code
    M70
  • Owners
Mark Drawing Code
3
Mark Identification
RENEO PHARMACEUTICALS
Case File Statements
  • DM0000: The mark consists of five rows of dots that form a circular shape positioned to the left of the words "Reneo Pharmaceuticals".
  • GS0051: Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of liver and kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 11/14/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/18/2024 - 5 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/13/2023 - 11 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/14/2023 - 11 months ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/21/2024 - 5 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/21/2024 - 5 months ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/16/2024 - a month ago
    8 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 10/16/2024 - a month ago
    9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 6/21/2024 - 5 months ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT